Products for Research Use Only
RegisterLogin

Deruxtecan-d4

CAT: 0804-HY-13631ES-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-13631ES-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Deruxtecan-d4 is deuterium labeled Deruxtecan. Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and a maleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402.
CAS Number
2760715-91-9
Product Name Alternative
MC-GGFG-DXD-d4
UNSPSC
12352005
Target
Drug-Linker Conjugates for ADC; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Antibody-drug Conjugate/ADC Related; Others
Field of Research
Others
Solubility
10 mM in DMSO
Smiles
O=C(C=CC1=O)N1CCCCCC(NCC(NCC(N[C@@H](CC2=CC=CC=C2)C(NC([2H])([2H])C(NCOC([2H])([2H])C(N[C@@H]3C4=C5C(C(N6C5)=CC([C@](O)(C(OC7)=O)CC)=C7C6=O)=NC8=CC(F)=C(C)C(CC3)=C84)=O)=O)=O)=O)=O)=O
Molecular Formula
C52H52D4FN9O13
Molecular Weight
1038.08
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-13631E-01Deruxtecan
HY-P99813-01Patritumab deruxtecan
HY-164835-01VcMMAE-Deruxtecan
HY-138298A-01Trastuzumab deruxtecan
HY-P3371-01Ifinatamab deruxtecan
HY-13631ES3-01Deruxtecan-d2
HY-164734-01Raludotatug Deruxtecan
HY-13631EG-01Deruxtecan (GMP)
HY-13631ES1-01Deruxtecan-d6
HY-141598-01Datopotamab deruxtecan

Alternative Products

CatalogName
ZNC44013-01Deruxtecan
T83576-01(1R) -Deruxtecan
MBS5800151Datopotamab deruxtecan
A21522-10Deruxtecan 10mg
S0E0010Trastuzumab deruxtecan
D4004-1mgPatritumab deruxtecan
T77474-01Raludotatug deruxtecan
T201852-01Deruxtecan-Eribulin
A21522-50Deruxtecan 50mg
A21522-5Deruxtecan 5mg

Popular Products